BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17626838)

  • 1. Inactivation of PI3Kgamma and PI3Kdelta distorts T-cell development and causes multiple organ inflammation.
    Ji H; Rintelen F; Waltzinger C; Bertschy Meier D; Bilancio A; Pearce W; Hirsch E; Wymann MP; Rückle T; Camps M; Vanhaesebroeck B; Okkenhaug K; Rommel C
    Blood; 2007 Oct; 110(8):2940-7. PubMed ID: 17626838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficiency of PI3-Kinase catalytic isoforms p110γ and p110δ in mice enhances the IL-17/G-CSF axis and induces neutrophilia.
    Bucher K; Schmitt F; Mothes B; Blumendeller C; Schäll D; Piekorz R; Hirsch E; Nürnberg B; Beer-Hammer S
    Cell Commun Signal; 2017 Jul; 15(1):28. PubMed ID: 28724384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential role of PI3Kdelta and PI3Kgamma in thymocyte survival.
    Swat W; Montgrain V; Doggett TA; Douangpanya J; Puri K; Vermi W; Diacovo TG
    Blood; 2006 Mar; 107(6):2415-22. PubMed ID: 16304053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The PI3K p110delta controls T-cell development, differentiation and regulation.
    Patton DT; Garçon F; Okkenhaug K
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):167-71. PubMed ID: 17371229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The catalytic PI3K isoforms p110gamma and p110delta contribute to B cell development and maintenance, transformation, and proliferation.
    Beer-Hammer S; Zebedin E; von Holleben M; Alferink J; Reis B; Dresing P; Degrandi D; Scheu S; Hirsch E; Sexl V; Pfeffer K; Nürnberg B; Piekorz RP
    J Leukoc Biol; 2010 Jun; 87(6):1083-95. PubMed ID: 20200404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p110γ/δ Double-Deficiency Induces Eosinophilia and IgE Production but Protects from OVA-Induced Airway Inflammation.
    Mothes B; Bucher K; Ammon-Treiber S; Schwab M; Piekorz RP; Hirsch E; Nürnberg B; Beer-Hammer S
    PLoS One; 2016; 11(7):e0159310. PubMed ID: 27442134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of T cell alloimmunity by PI3Kγ and PI3Kδ.
    Uehara M; McGrath MM; Ohori S; Solhjou Z; Banouni N; Routray S; Evans C; DiNitto JP; Elkhal A; Turka LA; Strom TB; Tullius SG; Winkler DG; Azzi J; Abdi R
    Nat Commun; 2017 Oct; 8(1):951. PubMed ID: 29038423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The p110 delta isoform of phosphatidylinositol 3-kinase controls the quality of secondary anti-Leishmania immunity by regulating expansion and effector function of memory T cell subsets.
    Liu D; Uzonna JE
    J Immunol; 2010 Mar; 184(6):3098-105. PubMed ID: 20154209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essential role of phosphoinositide 3-kinase gamma in eosinophil chemotaxis within acute pulmonary inflammation.
    Thomas M; Edwards MJ; Sawicka E; Duggan N; Hirsch E; Wymann MP; Owen C; Trifilieff A; Walker C; Westwick J; Finan P
    Immunology; 2009 Mar; 126(3):413-22. PubMed ID: 18754810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The p110delta isoform of phosphatidylinositol 3-kinase controls susceptibility to Leishmania major by regulating expansion and tissue homing of regulatory T cells.
    Liu D; Zhang T; Marshall AJ; Okkenhaug K; Vanhaesebroeck B; Uzonna JE
    J Immunol; 2009 Aug; 183(3):1921-33. PubMed ID: 19596993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The p110delta isoform of phosphoinositide 3-kinase controls clonal expansion and differentiation of Th cells.
    Okkenhaug K; Patton DT; Bilancio A; Garçon F; Rowan WC; Vanhaesebroeck B
    J Immunol; 2006 Oct; 177(8):5122-8. PubMed ID: 17015696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enforced expression of GATA-3 in transgenic mice inhibits Th1 differentiation and induces the formation of a T1/ST2-expressing Th2-committed T cell compartment in vivo.
    Nawijn MC; Dingjan GM; Ferreira R; Lambrecht BN; Karis A; Grosveld F; Savelkoul H; Hendriks RW
    J Immunol; 2001 Jul; 167(2):724-32. PubMed ID: 11441076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of PI3Kδ induces vascular injury and promotes aneurysm development by upregulating the AP-1/MMP-12 pathway in macrophages.
    Zheng L; Xing L; Zeng C; Wu T; Gui Y; Li W; Lan T; Yang Y; Gu Q; Qi C; Zhang Q; Tang F; He X; Wang L
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):368-77. PubMed ID: 25503990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of dual inhibitors of the immune cell PI3Ks p110delta and p110gamma: a prototype for new anti-inflammatory drugs.
    Williams O; Houseman BT; Kunkel EJ; Aizenstein B; Hoffman R; Knight ZA; Shokat KM
    Chem Biol; 2010 Feb; 17(2):123-34. PubMed ID: 20189103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutting edge: T cell development requires the combined activities of the p110gamma and p110delta catalytic isoforms of phosphatidylinositol 3-kinase.
    Webb LM; Vigorito E; Wymann MP; Hirsch E; Turner M
    J Immunol; 2005 Sep; 175(5):2783-7. PubMed ID: 16116162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of PI3Kdelta and PI3Kgamma in inflammatory arthritis and tissue localization of neutrophils.
    Randis TM; Puri KD; Zhou H; Diacovo TG
    Eur J Immunol; 2008 May; 38(5):1215-24. PubMed ID: 18412166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Class IB-phosphatidylinositol 3-kinase (PI3K) deficiency ameliorates IA-PI3K-induced systemic lupus but not T cell invasion.
    Barber DF; Bartolomé A; Hernandez C; Flores JM; Fernandez-Arias C; Rodríguez-Borlado L; Hirsch E; Wymann M; Balomenos D; Carrera AC
    J Immunol; 2006 Jan; 176(1):589-93. PubMed ID: 16365454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting PI3Kδ and PI3Kγ signalling disrupts human AML survival and bone marrow stromal cell mediated protection.
    Pillinger G; Loughran NV; Piddock RE; Shafat MS; Zaitseva L; Abdul-Aziz A; Lawes MJ; Bowles KM; Rushworth SA
    Oncotarget; 2016 Jun; 7(26):39784-39795. PubMed ID: 27174919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-4 is required for the induction of lung Th2 mucosal immunity.
    Coyle AJ; Le Gros G; Bertrand C; Tsuyuki S; Heusser CH; Kopf M; Anderson GP
    Am J Respir Cell Mol Biol; 1995 Jul; 13(1):54-9. PubMed ID: 7598937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Taking PI3Kδ and PI3Kγ one step ahead: dual active PI3Kδ/γ inhibitors for the treatment of immune-mediated inflammatory diseases.
    Rommel C
    Curr Top Microbiol Immunol; 2010; 346():279-99. PubMed ID: 20593311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.